About Us │Kedrion.com
You are now leaving www.kedrion.hu. Medical information including licensed uses may be different outside of the EU countries.
NO
YES

HUMAN BioPlazma Kft. is part of Kedrion Biopharma, an international company specializing in the collection and fractionation of blood plasma to produce and distribute plasma-derived therapeutic products for use in treating serious diseases, disorders and conditions such as hemophilia and immune system deficiencies.

Kedrion was established in Italy in 2001, but the roots of the companies from which it was born stretch back several decades in the production of blood and plasma derived products. A primarily family-owned business, it places a high value on the welfare of those who benefit from its products and on the people and communities where it operates. HUMAN BioPlazma became part of Kedrion in 2008, but its own roots extend back to 1922 when its predecessor, the Phylaxia Vaccine Manufacturing company founded its Human Department in Budapest.

HUMAN BioPlazma collects plasma in its own plasma collection centers applying apheresis technology, and also receives plasma for further processing deriving from the excess amounts of whole blood donations, which are not required for transfusiology purposes as the partner of the Hungarian National Blood Transfusion Service.

We have been well-matched to join Kedrion, sharing its commitments and values of quality products, community values and a highly professional workforce.

 

Kedrion around the world

Kedrion Biopharma has a long history of collaboration with the Italian National Health System, and partners the country in its move toward self-sufficiency in plasma-derived products. We bring this experience and the dedication to that goal to potential partners around the world. In recent years Kedrion has expanded its operations – not only into the United States through Kedrion Biopharma Inc., but into Germany and Hungary as well. It now has a market presence in about 100 countries. In addition, it has acquired collection and production capacity as well as the rights to significant products for treating hemophilia and preventing Rh sensitization, a condition which can lead to Hemolytic Disease of the Fetus and the Newborn (HDFN).

Kedrion looks forward to continued expansion and the wider sharing of its experience, know-how and technology to foster self-sufficiency of plasma-derived products in healthcare systems and communities around the world and to bring healthier and less restricted lives to people suffering from rare disorders.

 

 

Our vision

Everyone has the right to life, liberty and security of person* Sometimes, natural, accidental or social causes obstruct the natural right to life, liberty and personal security. Because of the special nature of its products, Kedrion supports people, communities and institutions in reducing or removing those obstacles that prevent people enjoying such rights. Kedrion helps turn the natural rights (life, liberty, security) into the social right to live in the best possible conditions.

For this reason, it collects and converts, makes active and usable that vital energy that is generated and regenerated, preserved and carried through blood; so that it can be transferred from one Human being to the next, and anyone can enjoy one’s fundamental rights.

*Universal Declaration of Human Rights, art. 3.

 

Our mission

Kedrion editorial media

Kedrion produces and distributes Human plasma-derived medicinal products, which can improve people’s quality of life. It works to maintain its excellent industry standards and aspires to ongoing improvement, in order to retain its leading position in Italy and increase its share of the international market. It works to strengthen its role as the accredited partner of the medical, scientific and institutional communities.

Kedrion’s ambition is to enhance its worldwide role as a strategic partner of the national health systems of those countries which aim to become self-sufficient in the availability of plasma-derived products, also via technology transfer.

Kedrion produces wealth for its investors, for its employees, for the local community, and does it consistently with its own vision and with its values, which are responsibility, transparency, confidence in and respect for people.

Our history

OUR COMMITMENTS

SOCIAL RESPONSIBILITY

To act as responsible global citizens respecting all the communities with whom and for whom we work.

TRANSPARENCY

To make accurate and comprehensive information available to all stakeholders.

 

QUALITY AND SAFETY

To demonstrate our care and respect for our clients, our collaborators and our employees by continuous emphasis on the quality and safety of all our products and processes.